OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc. financial statements

OnKure Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 59.52M10-K
Cash and equivalentsUSD 59.05M10-Q
Total debtUSD 549KEODHD

OnKure Therapeutics, Inc. financials on 6ix · OnKure Therapeutics, Inc. on 6ix